slides · global inventory
Present Solution
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 24,547
Current window 16,231-16,260
Pages 819
Rows per page 30
Slide function
16,231-16,260 of 24,547
17
ModivCare | Investor Presentation Deck | 36 slidesModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Business ModelLoop · Quick Win Big Bet1 hit
20
The slide uses a mix of qualitative service descriptions and quantitative financial performance data.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Business ModelLoop · Quick Win Big Bet1 hit
07
Momentus | Results Presentation Deck | 16 slidesMomentus | Results Presentation Deck | 16 slides · Momentus
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
10
Uses a puzzle piece metaphor to represent integration and a funnel-like structure to show market application.Nano Dimension | Shareholder Engagement Presentation Deck | 34 slides · Nano Dimension
Shareholder letter Investor relations Beat · InterestLoop · Golden Circle1 hit
07
Nextdoor | Investor Presentation Deck | 34 slidesNextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
20
The slide uses a three-column layout, each featuring a mobile app screenshot representing a specific use case.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations 1 hit
21
The slide uses three mobile UI screenshots to demonstrate product functionality.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations 1 hit
07
The slide highlights a specific operational deployment plan for 9 mobile fuelers.Nikola | Results Presentation Deck | 19 slides · Nikola
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
06
Uses a Venn diagram to illustrate the intersection of Kinase Resistance and Kinase Selectivity.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
08
Uses a visual comparison framework to illustrate the mechanism of action and clinical benefit of selectivity.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
Nuvalent | Investor Presentation Deck | 39 slidesNuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
The slide uses dot plots for IC50 data and a bar chart for tumor regression efficacy.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
14
The slide uses a bar chart to compare brain penetrance and a grouped bar chart to show selectivity indices across multiple drugs.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
27
The slide uses a list of icons to represent key features of the drug candidate.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
30
The slide uses three distinct chart types to demonstrate efficacy, pharmacokinetics, and selectivity.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
33
The slide outlines the key therapeutic advantages of the drug candidate NVL-330.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
34
Includes three distinct charts: a dot plot for IC50, a bar chart for selectivity index, and a bar chart for brain penetrance.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
38
Includes a molecular structure visualization.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
08
Includes a molecular pathway diagram and a Western blot image as evidence.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
Uses a structural biology diagram to illustrate mechanism of action.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
Includes a biological pathway diagram, microscopy images, and an IC50 dose-response curve.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
Includes two distinct experimental setups: cell proliferation assays and mouse tumor growth models.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
Includes a list of clinical citations at the bottom.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · Solution1 hit
10
Uses a numbered process flow diagram to explain medical device operation.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations 1 hit
19
The slide uses a split-pane layout: left side for problem/market context, right side for product solution.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations 1 hit
11
The slide uses a linear process flow to describe the core value proposition.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses a process-oriented framework to categorize various proprietary technologies.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
The slide uses a process-oriented header (Create, Screen, Deliver) and lists specific proprietary technologies (OmniRat, OmniMouse, etc.) alongside value propositions.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide illustrates the genetic mechanism of the platform, showing how human V, D, and J genes are combined with rat constant regions to facilitate robust immune responses, followed by conversion to fully human antibodies.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
Uses a phylogenetic-style timeline to show the split between avian and mammalian lineages.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit